Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioxcel Therapeutics Inc (NQ: BTAI ) 0.7100 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bioxcel Therapeutics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > 12 Health Care Stocks Moving In Thursday's After-Market Session February 08, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Index Up 26% In December December 29, 2023 With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. Via Talk Markets AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week December 17, 2023 A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Long Term Investor Notice: Investigation of Potential Wrongdoing December 08, 2023 San Diego, CA -- (SBWIRE) -- 12/08/2023 -- An investigation on behalf of current long-term investors in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) concerning potential breaches of fiduciary... Via SBWire Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November December 06, 2023 The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Expert Ratings for BioXcel Therapeutics November 15, 2023 Via Benzinga Recap: BioXcel Therapeutics Q3 Earnings November 14, 2023 Via Benzinga Earnings Outlook For BioXcel Therapeutics November 13, 2023 Via Benzinga Unlocking AI investment opportunities in healthcare November 16, 2023 AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. Via MarketBeat Topics Artificial Intelligence ETFs Exposures Artificial Intelligence Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 14, 2023 Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. Via Benzinga Where BioXcel Therapeutics Stands With Analysts September 08, 2023 Via Benzinga Why Is Dementia Focused BioXcel Therapeutics Stock Trading Lower Today? November 14, 2023 BioXcel Therapeutics Inc (NASDAQ: BTAI) announced alignment with the FDA's recommendation for a Phase 3 trial in the TRANQUILITY program of BXCL501 for acute treatment of agitation associated Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 14, 2023 Via Benzinga BioXcel Therapeutics Reveals Survival Data From Prostate Cancer Combo Therapy Trial November 08, 2023 BioXcel Therapeutics Inc (NASDAQ: BTAI) announced overall survival (OS) data from its Phase 2 trial of BXCL701 in combination with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) in patients wi Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 30, 2023 Via Benzinga Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results October 25, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76.... Via Benzinga Topics Stocks Exposures US Equities Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 25, 2023 Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session October 25, 2023 Via Benzinga BioXcel Therapeutics Inc. (NASDAQ: BTAI) Leading the Way in Wednesday Trading Based on Percentage Gain October 25, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Shell Layoffs 2023: What to Know About the Latest SHEL Job Cuts October 25, 2023 Shell layoffs are on the horizon as the petrol company prepares to cut 200 jobs in 2024 with another 130 jobs under review. Via InvestorPlace Topics Energy Workforce Exposures Fossil Fuels Layoff EVGO Stock Slips as TD Cowen Downgrades EVgo October 25, 2023 EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut. Via InvestorPlace Nasdaq Down 1.5%; Microsoft Posts Upbeat Results October 25, 2023 U.S. stocks traded lower this morning, with the Nasdaq Composite falling 1.5% on Wednesday. Following the market opening Wednesday, the Dow traded down 0.26% to 33,053.68 while the NASDAQ fell 1.50% to... Via Benzinga Topics Stocks Exposures US Equities Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today? October 25, 2023 BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 25, 2023 Via Benzinga BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm October 11, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock October 05, 2023 Truist downgraded BioXcel Therapeutics Inc (NASDAQ: BTAI) from Buy to Hold, citing significant near-term funding and Via Benzinga Why Shares of BioXcel Therapeutics Fell This Week September 28, 2023 The company's co-founder is leaving, and layoffs are coming. Via The Motley Fool Topics Workforce Exposures Layoff Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 October 05, 2023 Via Benzinga NASDAQ: BTAI Investor Alert: Deadline on September 5, 2023 in Lawsuit Against BioXcel Therapeutics, Inc. September 05, 2023 San Diego, CA -- (SBWIRE) -- 09/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 5, 2023 in the lawsuit filed for certain investors of BioXcel Therapeutics,... Via SBWire Topics Lawsuit Exposures Financial Legal BTAI DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI September 04, 2023 From The Rosen Law Firm, P.A. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.